Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel-Reference-Cited by-同舟云学术

Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel

Published:2016-09-21 Issue:4 Volume:175 Page:588-601
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Abla Oussama¹,Kutny Matthew A.²,Testi Anna Maria³,Feusner James H.⁴,Creutzig Ursula⁵,Gregory John⁶,Gibson Brenda⁷,Leverger Guy⁸,Ribeiro Raul C.⁹,Smith Owen¹⁰,Locatelli Franco¹¹¹²,Kaspers Gertjan¹³¹⁴

Affiliation:

1. Division of Hematology/Oncology; Department of Pediatrics; the Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

2. Department of Pediatrics; Division of Hematology/Oncology; University of Alabama at Birmingham; Birmingham AL USA

3. Department of Cellular Biotechnologies and Haematology; Sapienza University of Rome; Rome Italy

4. Division of Hematology/Oncology; Children's Hospital and Research Center Oakland; Oakland CA USA

5. Paediatric Haematology/Oncology; Hannover Medical School; Hannover Germany

6. Atlantic Health System; Goryeb Children's Hospital; Morristown NJ USA

7. Department of Haematology and Oncology; Royal Hospital for Children; Glasgow UK

8. Haematology/Oncology; Hôpital Armand Trousseau; Paris France

9. Department of Oncology; Division of Leukemia/Lymphoma; St. Jude Children's Research Hospital; Memphis TN USA

10. Department of Haematology/Oncology; Our Lady's Children's Hospital; Dublin Ireland

11. Department of Paediatric Haematology and Oncology; IRCCS Ospedale Pediatrico Bambino Gesù; Rome Italy

12. University of Pavia; Pavia Italy

13. Paediatric Oncology; VU University Medical Centre; Amsterdam The Netherlands

14. Academy of Princess Máxima Centre for Paediatric Oncology; Utrecht The Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14313/fullpdf

Reference87 articles.

1. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience;Adès;Blood,2010

2. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia;Aribi;Cancer,2007

3. Unusual sites of involvement by hematologic malignancies. Case 3. External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide;Au;Journal of Clinical Oncology,2001

4. Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment;Au;Leukemia Research,2008

5. Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients;Au;Pediatric Blood & Cancer,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Promyelocytic Leukemia;Pediatric Oncology;2024

2. Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review;Pediatric Health, Medicine and Therapeutics;2023-05

3. Childhood Acute Promyelocytic Leukemia;Reference Module in Biomedical Sciences;2023

4. HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA?;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

5. Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia;Journal of Pediatric Hematology/Oncology;2022-01-28